Serum Level of Plasminogen Activator Inhibitor Type-1 in Addicted Patients with Coronary Artery Disease

BACKGROUND: Plasminogen activator inhibitor-1 (PAI-1) is a glycoprotein with inhibitory effects on the formation of plasmin from plasminogen by plasminogen activator. Thus, it prevents clot lysis in vessel walls. Several evidences prove the relationship between coronary artery disease and response t...

Descripción completa

Detalles Bibliográficos
Autores principales: Forood, Afsaneh, Malekpour-Afshar, Reza, Mahdavi, Amin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kerman University of Medical Sciences 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4354217/
https://www.ncbi.nlm.nih.gov/pubmed/25984279

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4354217/
https://www.ncbi.nlm.nih.gov/pubmed/25984279

Ejemplares similares